NXTC - NextCure  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NXTC is currently covered by 1 analysts with an average price target of $6.73. This is a potential upside of $6.28 (1395.56%) from yesterday's end of day stock price of $0.45.

NextCure 's activity chart (see below) currently has 48 price targets and 39 ratings on display. The stock rating distribution of NXTC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.04% with an average time for these price targets to be met of 53.57 days.

Highest price target for NXTC is $4, Lowest price target is $4, average price target is $4.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 02-Aug-2024. First documented stock forecast 03-Jun-2019.

Currently out of the existing stock ratings of NXTC, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4

$2.92 (270.37%)

$4

9 months 7 days ago
(02-Aug-2024)

0/7 (0%)

$2.4 (150.00%)

Hold

$16

2 years 6 months 5 days ago
(04-Nov-2022)

0/3 (0%)

$11.08 (225.20%)

Buy

$6

$4.92 (455.56%)

$13

2 years 6 months 6 days ago
(03-Nov-2022)

3/14 (21.43%)

$3.49 (139.04%)

56

Buy

$15

$13.92 (1288.89%)

$19

2 years 8 months 16 days ago
(23-Aug-2022)

1/4 (25%)

$10.56 (237.84%)

185

Buy

$14

$12.92 (1196.30%)

$14

3 years 3 days ago
(06-May-2022)

0/3 (0%)

$10.2 (268.42%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NXTC (NextCure ) average time for price targets to be met?

On average it took 53.57 days on average for the stock forecasts to be realized with a an average price target met ratio 27.04

Which analyst has the current highest performing score on NXTC (NextCure ) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on NXTC (NextCure ) with a proven track record?

CHAD MESSER

Which analyst has the most public recommendations on NXTC (NextCure )?

Edward Tenthoff works at PIPER SANDLER and has 35 price targets and 23 ratings on NXTC

Which analyst is the currently most bullish on NXTC (NextCure )?

Asthika Goonewardene with highest potential upside - $13.92

Which analyst is the currently most reserved on NXTC (NextCure )?

Aydin Huseynov with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?